These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 35805135)

  • 21. HSP70 Family in Cancer: Signaling Mechanisms and Therapeutic Advances.
    Zhao K; Zhou G; Liu Y; Zhang J; Chen Y; Liu L; Zhang G
    Biomolecules; 2023 Mar; 13(4):. PubMed ID: 37189349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of Benign Prostate Hyperplasia Based on Magnetic Resonance Imaging Are Correlated With Lower Urinary Tract Symptoms and Continence in Men Undergoing a Robot-assisted Radical Prostatectomy for Prostate Cancer.
    Grivas N; van der Roest R; Tillier C; Schouten D; van Muilekom E; Schoots I; van der Poel H; Heijmink S
    Urology; 2017 Sep; 107():196-201. PubMed ID: 28601562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia.
    Popovics P; Awadallah WN; Kohrt SE; Case TC; Miller NL; Ricke EA; Huang W; Ramirez-Solano M; Liu Q; Vezina CM; Matusik RJ; Ricke WA; Grabowska MM
    Prostate; 2020 Jul; 80(10):731-741. PubMed ID: 32356572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Androgen receptor roles in the development of benign prostate hyperplasia.
    Izumi K; Mizokami A; Lin WJ; Lai KP; Chang C
    Am J Pathol; 2013 Jun; 182(6):1942-9. PubMed ID: 23570837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential ameliorative effects of epigallocatechin‑3‑gallate against testosterone-induced benign prostatic hyperplasia and fibrosis in rats.
    Zhou J; Lei Y; Chen J; Zhou X
    Int Immunopharmacol; 2018 Nov; 64():162-169. PubMed ID: 30179845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom-related outcomes: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Breyer BN; Huang WY; Rabkin CS; Alderete JF; Pakpahan R; Beason TS; Kenfield SA; Mabie J; Ragard L; Wolin KY; Grubb RL; Andriole GL; Sutcliffe S
    BJU Int; 2016 Jan; 117(1):145-54. PubMed ID: 25601300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Translational pharmacology in aging men with benign prostatic hyperplasia: molecular and clinical approaches to alpha1-adrenoceptors.
    Kojima Y; Kubota Y; Sasaki S; Hayashi Y; Kohri K
    Curr Aging Sci; 2009 Dec; 2(3):223-39. PubMed ID: 20021417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocrinology of the Aging Prostate: Current Concepts.
    Cannarella R; Condorelli RA; Barbagallo F; La Vignera S; Calogero AE
    Front Endocrinol (Lausanne); 2021; 12():554078. PubMed ID: 33692752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benign prostate hyperplasia and stem cells: a new therapeutic opportunity.
    Notara M; Ahmed A
    Cell Biol Toxicol; 2012 Dec; 28(6):435-42. PubMed ID: 23065175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetes, growth hormone-insulin-like growth factor pathways and association to benign prostatic hyperplasia.
    Wang Z; Olumi AF
    Differentiation; 2011; 82(4-5):261-71. PubMed ID: 21536370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of inflammation in lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) and its potential impact on medical therapy.
    Ficarra V; Rossanese M; Zazzara M; Giannarini G; Abbinante M; Bartoletti R; Mirone V; Scaglione F
    Curr Urol Rep; 2014 Dec; 15(12):463. PubMed ID: 25312251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperglycemia and insulin resistance and the risk of BPH/LUTS: an update of recent literature.
    Breyer BN; Sarma AV
    Curr Urol Rep; 2014 Dec; 15(12):462. PubMed ID: 25287259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical significance of peripheral zone thickness in men with lower urinary tract symptoms/benign prostatic hyperplasia.
    Kwon JK; Han JH; Choi HC; Kang DH; Lee JY; Kim JH; Oh CK; Choi YD; Cho KS
    BJU Int; 2016 Feb; 117(2):316-22. PubMed ID: 25807886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epithelial-to-mesenchymal transition and estrogen receptor α mediated epithelial dedifferentiation mark the development of benign prostatic hyperplasia.
    Shao R; Shi J; Liu H; Shi X; Du X; Klocker H; Lee C; Zhu Y; Zhang J
    Prostate; 2014 Jun; 74(9):970-82. PubMed ID: 24752964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical intervention for symptomatic benign prostatic hyperplasia is correlated with expression of the AP-1 transcription factor network.
    Lin-Tsai O; Clark PE; Miller NL; Fowke JH; Hameed O; Hayward SW; Strand DW
    Prostate; 2014 May; 74(6):669-79. PubMed ID: 24500928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH).
    Gandaglia G; Briganti A; Gontero P; Mondaini N; Novara G; Salonia A; Sciarra A; Montorsi F
    BJU Int; 2013 Aug; 112(4):432-41. PubMed ID: 23650937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive patient evaluation for benign prostatic hyperplasia.
    Jepsen JV; Bruskewitz RC
    Urology; 1998 Apr; 51(4A Suppl):13-8. PubMed ID: 9586591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Sutcliffe S; Grubb Iii RL; Platz EA; Ragard LR; Riley TL; Kazin SS; Hayes RB; Hsing AW; Andriole GL;
    BJU Int; 2012 Oct; 110(7):1050-9. PubMed ID: 22429766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophages affect immune inflammation and proliferation in benign prostatic hyperplasia via androgen receptor and CD40/CD40L signaling pathway.
    Yang M; Xu Z; Zhuang Z
    Tissue Cell; 2020 Jun; 64():101343. PubMed ID: 32473708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prostatic fibrosis: Progress in studies].
    Zhang JC; Zhao F; Duan Y
    Zhonghua Nan Ke Xue; 2020 Jan; 26(1):83-87. PubMed ID: 33345483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.